Likewise, SERCA2 protein levels remained unchanged in WDR12-treated hearts post-infarction and in Ang II-mediated hypertension, whereas WDR12-induced impairment of LV systolic function was associated with the reduction of SERCA2 expressions in normal hearts. This evidence concerns the gene WDR12 and Hypertension.